PROFESSOR-LED CARE IN ELITE SPORTDossier access · personal handling

Procedures & advertising claims / Motefit

Tenchim

When earlier surgery becomes a later contractual risk.

Tenchim · Motefit · Japan · Public reporting from 2020; judgment in 2024

Judgment · Appeal documented

Earlier surgery becomes a central question in a later campaign.

The case & the HPA perspective
Tenchim, an editorial studio portrait from ORICON.

Tenchim, an editorial studio portrait from ORICON. · Photo: Daisuke Ozaki (尾崎大輔); © oricon ME inc. · Individual usage licence to be confirmed before publication· Image reference for this local draft; confirm a usage licence before publication.

Editorial portrait. Not a photograph of HPA treatment or a before-and-after comparison.

01 / THE DOCUMENTED EVENTS

What is on the public record.

A breast augmentation performed before the partnership became the subject of a dispute over advertising for a night-time bra. The company brought a counterclaim concerning the undisclosed surgery. In 2024, the Tokyo District Court awarded it approximately ¥384.6 million. An appeal is documented; this account does not establish a verified final judgment.

02 / THE SPECIFIC RISK

What this case reveals about a partnership.

Advertising may attribute a visible result to a cause that is not supported by the person's history.

03 / WHERE HPA COULD HELP

Where thoughtful care could make a contribution.

A confidential baseline profile and a clear treatment record could provide a stronger factual basis. Information would be shared only where necessary for a legitimate purpose and with the individual's permission. Whether a specific product claim is substantiated requires separate technical and legal advertising review; an HPA record is not evidence of a product's efficacy.

RESPONSIBILITY BEYOND THE CAMPAIGN

What kind of care does your partnership need?

Discuss care for your organisation

04 / SOURCES & CONTEXT

These publicly documented cases illustrate different risks: contract disputes, conflicting advertising claims, interrupted care and later negative associations with a brand. The people and companies are editorial case studies; their inclusion does not imply that HPA has cared for them. Each HPA perspective is a hypothetical application of our proposed services, not evidence that HPA could have prevented the events described.

These editorial portraits identify the people discussed. They may have been taken at a different time from the events in the case study. We draw no clinical findings or conclusions about treatment needs from their appearance.

Engagement, responsibilities and boundaries · HPA Transparency Register